Attached files
| file | filename |
|---|---|
| S-1MEF - S-1MEF - Phio Pharmaceuticals Corp. | d902036ds1mef.htm |
| EX-5.1 - EX-5.1 - Phio Pharmaceuticals Corp. | d902036dex51.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
RXi Pharmaceuticals Corporation
Marlborough, Massachusetts
We hereby consent to the incorporation by reference in this Registration Statement on Form S-1 filed pursuant to Rule 462(b) of the Securities Act of 1933, as amended, of our report dated March 30, 2015 relating to the financial statements of RXi Pharmaceuticals Corporation as of and for the years ended December 31, 2014 and 2013 which are included in Amendment No. 2 to the Registration Statement on Form S-1 (No. 333-203389).
We also consent to the reference to us under the heading “Experts” in Amendment No. 2 to the Registration Statement on Form S-1 (No. 333-203389).
/s/ BDO USA, LLP
Boston, Massachusetts
May 27, 2015